Consuelo Buttigliero

3.0k total citations · 1 hit paper
91 papers, 1.7k citations indexed

About

Consuelo Buttigliero is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Consuelo Buttigliero has authored 91 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 48 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Consuelo Buttigliero's work include Prostate Cancer Treatment and Research (52 papers), Radiopharmaceutical Chemistry and Applications (23 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Consuelo Buttigliero is often cited by papers focused on Prostate Cancer Treatment and Research (52 papers), Radiopharmaceutical Chemistry and Applications (23 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Consuelo Buttigliero collaborates with scholars based in Italy, France and United States. Consuelo Buttigliero's co-authors include Marcello Tucci, Giorgio V. Scagliotti, Massimo Di Maïo, Francesca Vignani, Valentina Bertaglia, Fabio Turco, Alfredo Berruti, Rosario Francesco Di Stefano, Paolo Bironzo and Cristian Fiori and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Consuelo Buttigliero

81 papers receiving 1.6k citations

Hit Papers

Talazoparib monotherapy in metastatic castration-resistan... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
    2021 183 citations Johann S. de Bono, Niven Mehra et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Consuelo Buttigliero Italy 23 1.0k 692 411 397 294 91 1.7k
Marcello Tucci Italy 24 1.3k 1.3× 748 1.1× 403 1.0× 369 0.9× 243 0.8× 100 1.9k
Philip J. Saylor United States 25 1.2k 1.1× 1.0k 1.5× 492 1.2× 393 1.0× 726 2.5× 82 2.5k
Daniel Keizman Israel 23 1.0k 1.0× 678 1.0× 320 0.8× 332 0.8× 291 1.0× 98 1.7k
Shuanzeng Wei United States 20 1.0k 1.0× 504 0.7× 908 2.2× 540 1.4× 326 1.1× 73 2.1k
G. Deplanque France 23 812 0.8× 1.3k 1.9× 633 1.5× 542 1.4× 225 0.8× 77 2.3k
Yong Mee Cho South Korea 22 807 0.8× 449 0.6× 687 1.7× 288 0.7× 491 1.7× 100 1.8k
Magdolna Dank Hungary 19 499 0.5× 730 1.1× 419 1.0× 394 1.0× 242 0.8× 120 1.5k
Deborah Bradley United States 19 792 0.8× 378 0.5× 502 1.2× 287 0.7× 229 0.8× 34 1.7k
Taro Iguchi Japan 18 1.2k 1.2× 314 0.5× 230 0.6× 403 1.0× 168 0.6× 69 1.6k

Countries citing papers authored by Consuelo Buttigliero

Since Specialization
Citations

This map shows the geographic impact of Consuelo Buttigliero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Consuelo Buttigliero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Consuelo Buttigliero more than expected).

Fields of papers citing papers by Consuelo Buttigliero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Consuelo Buttigliero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Consuelo Buttigliero. The network helps show where Consuelo Buttigliero may publish in the future.

Co-authorship network of co-authors of Consuelo Buttigliero

This figure shows the co-authorship network connecting the top 25 collaborators of Consuelo Buttigliero. A scholar is included among the top collaborators of Consuelo Buttigliero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Consuelo Buttigliero. Consuelo Buttigliero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fiorica, Francesco, Matteo Bauckneht, Jacopo Giuliani, et al.. (2025). Is [177Lu]Lu-PSMA-617 Redefining Value in mCRPC Care? A Meta-Analysis of Clinical and Economic Endpoints. Cancers. 17(13). 2247–2247.
3.
Turco, Fabio, Giorgio Treglia, Silke Gillessen, et al.. (2024). Maximal androgen blockade therapy (MAB) for prostate cancer (PC) and risk of bone fractures: A systematic literature review and meta-analysis.. Journal of Clinical Oncology. 42(16_suppl). e17111–e17111. 1 indexed citations
4.
5.
6.
Gillessen, Silke, Ursula Vogl, Luigi Tortola, et al.. (2024). Antiandrogens as Therapies for COVID-19: A Systematic Review. Cancers. 16(2). 298–298. 4 indexed citations
7.
Iacovelli, Roberto, Emanuela Fantinel, Davide Bimbatti, et al.. (2024). Efficacy of perioperative pembrolizumab treatment in patients with resectable metastases from kidney cancer: The PE-PE study.. Journal of Clinical Oncology. 42(4_suppl). TPS495–TPS495.
8.
Turco, Fabio, Rosario Francesco Di Stefano, Orazio Caffo, et al.. (2024). Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology. Clinical Genitourinary Cancer. 23(1). 102255–102255. 1 indexed citations
9.
Gillessen, Silke, Giuseppe Procopio, Stefanie Hayoz, et al.. (2023). Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16). Journal of Clinical Oncology. 41(20). 3608–3615. 2 indexed citations
10.
Turco, Fabio, Silke Gillessen, Giorgio Treglia, et al.. (2023). Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 27(3). 385–392. 4 indexed citations
11.
Tucci, Marcello, et al.. (2022). Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. Cells. 11(5). 803–803. 34 indexed citations
12.
Mehra, Niven, Karim Fizazi, Johann S. de Bono, et al.. (2022). Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. The Oncologist. 27(10). e783–e795. 11 indexed citations
13.
14.
Stefano, Rosario Francesco Di, Marcello Tucci, Fabio Turco, et al.. (2021). Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate. Prostate Cancer and Prostatic Diseases. 24(3). 812–825. 3 indexed citations
15.
Leone, Gianmarco, Consuelo Buttigliero, Rosario Francesco Di Stefano, et al.. (2020). Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. Critical Reviews in Oncology/Hematology. 152. 102994–102994. 11 indexed citations
16.
Iacovelli, Roberto, Chiara Ciccarese, Orazio Caffo, et al.. (2020). The prognostic value of pain in castration-sensitive prostate cancer. Prostate Cancer and Prostatic Diseases. 23(4). 654–660. 10 indexed citations
17.
Tucci, Marcello, Orazio Caffo, Consuelo Buttigliero, et al.. (2019). Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. Cancer Treatment Reviews. 74. 35–42. 22 indexed citations
18.
Stefano, Rosario Francesco Di, Consuelo Buttigliero, Emmanuele De Luca, et al.. (2018). Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review. Clinical Genitourinary Cancer. 16(6). e1087–e1090. 4 indexed citations
19.
Buttigliero, Consuelo, Marcello Tucci, Francesca Vignani, Giorgio V. Scagliotti, & Massimo Di Maïo. (2017). Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. Cancer Treatment Reviews. 54. 1–9. 45 indexed citations
20.
Iuliani, Michele, Francesco Pantano, Consuelo Buttigliero, et al.. (2015). Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. SHILAP Revista de lepidopterología. 11(4). 81–88.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcello Tucci Breakdown of academic impact, for papers by Philip J. Saylor Breakdown of academic impact, for papers by Daniel Keizman Breakdown of academic impact, for papers by Shuanzeng Wei Breakdown of academic impact, for papers by G. Deplanque Breakdown of academic impact, for papers by Yong Mee Cho Breakdown of academic impact, for papers by Magdolna Dank Breakdown of academic impact, for papers by Deborah Bradley Breakdown of academic impact, for papers by Taro Iguchi
Rankless by CCL
2026